362 related articles for article (PubMed ID: 7859067)
1. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
Sullivan AF; Hewett K; Dickenson AH
Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation.
Stanfa LC; Dickenson AH
Br J Pharmacol; 1993 Apr; 108(4):967-73. PubMed ID: 8485635
[TBL] [Abstract][Full Text] [Related]
3. Naltrindole, an opioid delta antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat.
Ossipov MH; Kovelowski CJ; Vanderah T; Porreca F
Neurosci Lett; 1994 Nov; 181(1-2):9-12. PubMed ID: 7898778
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of the mu but not delta opioid receptor subtype in the synergistic interaction between opioid and alpha 2 adrenergic antinociception in the rat spinal cord.
Sullivan AF; Kalso EA; McQuay HJ; Dickenson AH
Neurosci Lett; 1992 May; 139(1):65-8. PubMed ID: 1357605
[TBL] [Abstract][Full Text] [Related]
5. Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and delta opioid antinociception in the rat spinal cord.
Magnuson DS; Sullivan AF; Simonnet G; Roques BP; Dickenson AH
Neuropeptides; 1990 Aug; 16(4):213-8. PubMed ID: 2177165
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
[TBL] [Abstract][Full Text] [Related]
7. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
Zhou Y; Sun YH; Zhang ZW; Han JS
Eur J Pharmacol; 1993 Apr; 234(2-3):147-54. PubMed ID: 8387008
[TBL] [Abstract][Full Text] [Related]
8. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat.
Friedrich AE; Gebhart GF
J Pharmacol Exp Ther; 2000 Feb; 292(2):538-44. PubMed ID: 10640290
[TBL] [Abstract][Full Text] [Related]
9. The antinociceptive actions of dexmedetomidine on dorsal horn neuronal responses in the anaesthetized rat.
Sullivan AF; Kalso EA; McQuay HJ; Dickenson AH
Eur J Pharmacol; 1992 Apr; 215(1):127-33. PubMed ID: 1355441
[TBL] [Abstract][Full Text] [Related]
10. Postnatal development of multiple opioid receptors in the spinal cord and development of spinal morphine analgesia.
Rahman W; Dashwood MR; Fitzgerald M; Aynsley-Green A; Dickenson AH
Brain Res Dev Brain Res; 1998 Jun; 108(1-2):239-54. PubMed ID: 9693800
[TBL] [Abstract][Full Text] [Related]
11. Interaction between opiate subtype and alpha-2 adrenergic agonists in suppression of noxiously evoked activity of WDR neurons in the spinal dorsal horn.
Omote K; Kitahata LM; Collins JG; Nakatani K; Nakagawa I
Anesthesiology; 1991 Apr; 74(4):737-43. PubMed ID: 1672579
[TBL] [Abstract][Full Text] [Related]
12. A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test.
Noble F; Blommaert A; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 1995 Jan; 273(1-2):145-51. PubMed ID: 7737308
[TBL] [Abstract][Full Text] [Related]
13. Stress reduces morphine's antinociceptive potency: dependence upon spinal cholecystokinin processes.
Hawranko AA; Smith DJ
Brain Res; 1999 Apr; 824(2):251-7. PubMed ID: 10196456
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
[TBL] [Abstract][Full Text] [Related]
15. Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain.
Noble F; Derrien M; Roques BP
Br J Pharmacol; 1993 Aug; 109(4):1064-70. PubMed ID: 8401918
[TBL] [Abstract][Full Text] [Related]
16. The antinociceptive action of an alpha 2-adrenoceptor agonist in the spinal dorsal horn is due to a direct spinal action and not to activation of descending inhibition.
Hämäläinen MM; Pertovaara A
Brain Res Bull; 1995; 37(6):581-7. PubMed ID: 7670881
[TBL] [Abstract][Full Text] [Related]
17. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
[TBL] [Abstract][Full Text] [Related]
18. Enhanced alpha-2 adrenergic controls and spinal morphine potency in inflammation.
Stanfa LC; Dickenson AH
Neuroreport; 1994 Jan; 5(4):469-72. PubMed ID: 8003677
[TBL] [Abstract][Full Text] [Related]
19. Cross-tolerance between mu opioid and alpha-2 adrenergic receptors, but not between mu and delta opioid receptors in the spinal cord of the rat.
Kalso EA; Sullivan AF; McQuay HJ; Dickenson AH; Roques BP
J Pharmacol Exp Ther; 1993 May; 265(2):551-8. PubMed ID: 8098759
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
